Eli Lilly Unusual Options Activity
Eli Lilly Unusual Options Activity
From the overall spotted trades, 4 are puts, for a total amount of $161,203 and 7, calls, for a total amount of $504,204.Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
資金雄厚的鯨魚對艾莉莉表現出明顯的看好態度。
Looking at options history for Eli Lilly (NYSE:LLY) we detected 11 trades.
查看艾莉莉（紐交所：LLY）的期權歷史，我們發現了11筆交易。
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 27% with bearish.
如果我們考慮每筆交易的具體情況，可以準確地說，有45%的投資者以看好的預期開盤，27%則是看淡。
From the overall spotted trades, 4 are puts, for a total amount of $161,203 and 7, calls, for a total amount of $504,204.
從總體觀察到的交易中，有4筆看跌期權，總金額爲161,203美元，7筆看漲期權，總金額爲504,204美元。
Predicted Price Range
預測價格區間
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $920.0 for Eli Lilly during the past quarter.
分析這些合約的成交量和未平倉合約，似乎大玩家在過去一個季度內一直關注艾莉莉的價格區間在400.0到920.0美元之間。
Volume & Open Interest Trends
成交量和未平倉量趨勢
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
觀察成交量和未平倉合約是進行股票盡職調查的一個有見地的方法。
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
這些數據可以幫助你跟蹤在給定行使價格下，禮來公司的期權流動性和興趣。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $400.0 to $920.0 in the last 30 days.
下面，我們可以觀察到在過去30天中，禮來公司的所有鯨魚活動在$400.0到$920.0的行使價格區間內，看漲和看跌的成交量和未平倉合約的演變。
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Eli Lilly過去30天的期權成交量和未平倉合約量
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 06/20/25 | $83.2 | $79.5 | $79.5 | $800.00 | $151.0K | 345 | 29 |
| LLY | CALL | SWEEP | BEARISH | 06/20/25 | $65.05 | $62.55 | $63.32 | $840.00 | $107.7K | 606 | 17 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $398.45 | $392.45 | $397.55 | $400.00 | $79.5K | 374 | 0 |
| LLY | CALL | TRADE | BULLISH | 06/20/25 | $80.5 | $79.5 | $80.5 | $800.00 | $64.4K | 345 | 2 |
| LLY | PUT | TRADE | BULLISH | 01/17/25 | $55.1 | $52.3 | $53.35 | $830.00 | $53.3K | 1.0K | 1 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 行權價 | 總交易價格 | 未平倉合約 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | 交易 | 看淡 | 06/20/25 | $83.2 | $79.5 | $79.5 | $800.00 | $151.0K | 345 | 29 |
| LLY | 看漲 | 掃單 | 看淡 | 06/20/25 | $65.05 | $62.55 | $63.32 | $840.00 | 107.7K美元 | 606 | 17 |
| LLY | 看漲 | 交易 | 看好 | 01/17/25 | $398.45 | $392.45 | $397.55 | $400.00 | $79.5K | 374 | 0 |
| LLY | 看漲 | 交易 | 看好 | 06/20/25 | $80.5 | $79.5 | $80.5 | $800.00 | 64,400美元 | 345 | 2 |
| LLY | 看跌 | 交易 | 看好 | 01/17/25 | $55.1 | $52.3 | $53.35 | $830.00 | $53.3K | 1.0K | 1 |
About Eli Lilly
關於禮來公司
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來的主要產品包括用於癌症的Verzenio；用於心臟代謝的Mounjaro、Zepbound、Jardiance、Trulicity、Humalog和Humulin；以及用於免疫學的Taltz和Olumiant。
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在對圍繞禮來的期權交易進行徹底審查後，我們轉向更詳細地檢查公司。這包括評估其當前的市場狀態和表現。
Current Position of Eli Lilly
艾莉健康的當前狀況
- Trading volume stands at 120,979, with LLY's price down by -0.54%, positioned at $795.24.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 55 days.
- 成交量爲120,979，LLY的價格下跌了-0.54%，現報$795.24。
- RSI因子顯示該股票當前在超買和超賣之間處於中立狀態。
- 收益公告預計在55天后發佈。
Expert Opinions on Eli Lilly
專家對艾莉健康的看法
In the last month, 2 experts released ratings on this stock with an average target price of $998.5.
在過去一個月中，2位專家對該股票發佈了評級，平均目標價爲$998.5。
Turn $1000 into $1270 in just 20 days?
在短短20天內將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* Reflecting concerns, an analyst from Wolfe Research lowers its rating to Outperform with a new price target of $1000.* An analyst from B of A Securities has revised its rating downward to Buy, adjusting the price target to $997.
20年期權交易專業人士揭示了他的單行圖表技巧，顯示何時買入和賣出。複製他的交易，平均每20天獲利27%。點擊這裏獲取訪問權限。* 反映出擔憂，Wolfe Research的分析師將其評級下調至跑贏大盤，新的價格目標爲$1000。* 美國銀行證券的分析師已將其評級下調至買入，並將價格目標調整至$997。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
期權交易存在更高的風險和潛在的回報。聰明的交易者通過不斷學習、調整策略、監控多個因子，並密切關注市場動態來管理這些風險。通過Benzinga Pro的實時提醒，及時了解最新的禮來製藥期權交易信息。
譯文內容由第三人軟體翻譯。
